Skip to main content

Table 1 Demographic data and baseline characteristics of the study population (all patients, documentation in physician questionnaires)

From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program

Patient population

 

Patients enrolled [n]

731

Therapy discontinuation:

No [n]

614 [84 %]

 

Yes [n]

117 [16 %]

Duration of observation in C.A.R.E. [days], mean/median (range)

309/351 (8–699)

Baseline characteristics

 

Age [years], mean/median (range)

38.2 (+/−10,8)/ 39 (17–69)

Gender, female [%]

73.7

# Relapses 12 months prior to baseline [n], mean/median (range)

1.3/1.0 (0–6)

Duration of MS before baseline [years], mean/median (range)

5.2/2.0 (1–41)

Prior MS therapies [%]

  
 

No

485 [66.4 %]

 

Yes

245 [33.6 %]

 

Missing

1